Dr Anna Singleton is a Senior Research Fellow at the Daffodil Centre, a joint venture between the University of Sydney and Cancer Council NSW. Her research focuses on co-designing and implementing accessible, and scalable digital health services to improve health outcomes for people living with and beyond cancer.

We spoke with her about the EMPOWER-SMS clinical trial and what it aims to achieve for breast cancer patients.